Asthma Spacers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The asthma spacers market is segmented by Product Type (Aerochambers, Optichamber, Volumatic, and Inspirease), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-commerce), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Asthma Spacer Market
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 6.4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The asthma spacers market is expected to register a CAGR of 6.4% over the forecast period, 2022-2027.

The asthma spacers market is likely to grow even faster because of the COVID-19 crisis. Additionally, the threat will have a long-term influence on governments and regulatory agencies in terms of future pandemic preparedness. Because of the rising number of COVID-19 cases with respiratory symptoms, demand for asthma spacers has skyrocketed, and many patients have suffered acute respiratory disease syndrome (ARDS). Also, people with asthma (PWA) are at high risk of serious illness from COVID-19. Many regulatory bodies that regulate medical devices are reducing import limits, in addition to accelerating registration processes for required goods, all to ensure that laws do not restrict the development or supply of devices that could save lives. For instance, the United States Environmental Protection Agency (EPA) states that May is Asthma Awareness Month which has been created to raise awarness regarding the disease. Furthermore, awareness programs and well-coordinated asthma management programs, which are likely to have a positive impact on the adoption of asthma spacers due to precautionary measures which will eventually drive the asthma spacers market up to a certain extent globally.

Further, the increasing prevalence of chronic respiratory condition, growing awareness about the benefits of Spacers, and rising investments by public and private organizations in research and development activities for product innovation are among the major factors driving the growth of the studied market. Chronic respiratory disorders are among the most common non-communicable diseases worldwide because of the presence of noxious environmental, occupational, and behavioral inhalational exposures. According to the World Health Organization (WHO) asthma affected an estimated 262 million people in 2019 and caused 4,55,000, deaths. Such factors are likely to boost the adoption of asthma spacers devices, thereby contributing to the studied market growth.

According to the Asthma and Allergy Foundation of America (AAFA), in 2020 asthma affects over 25 million Americans. In 2019, about 20 million U.S. adults aged 18 and older have asthma. On average, 11 people in the U.S. die from asthma each day. As per the same source mentioned above in 2020, 4,145 people died from asthma. All of these deaths are avoidable with the right treatment and care. People with asthma may need to use their inhalers every day. Using a spacer device makes it easier to use an aerosol inhaler and helps the medicine reach the lungs more effectively. Therefore, the adoption of asthma spacer devices is poised to accelerate the asthma spacer market globally and is expected to increase in the future, thereby driving the growth of the studied market over the forecast period.

In addition, new product launches and strategic activities by major players in the market are positively affecting the growth of the market studied. For instance, in December 2019, as per the JOJ Nursing & Health Care, inhaled short-acting bronchodilators are the most used first-line medications used to treat exacerbations of wheezing or asthma. Additionally, in March 2021, Philip Morris announced a deal to buy Vectura at an enterprise value of USD 1.2 billion. The acquisition will accelerate Philip Morris Internationa (PMIs) beyond nicotine strategy and expand its product pipeline development capabilities in inhaled therapeutics. Thus, owing to the product launches and acquisitions, the studied market is expected to have significant growth over the forecast period.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. However, rising costs of these devices and a lack of awareness among people about the product. is likely to impede market growth.

Scope of the Report

As per the scope of the report, Asthma spacers are an external device that increases inhalation and actuation to improve drug delivery. Spacers help in administrating the right amount of medicine to the lungs when used along with the metered dose inhaler (MDI). The use of an asthma spacer helps to reduce medicine waste and limits the occurrence of dose-related side effects. The asthma spacers market is segmented by Product Type (Aerochambers, Optichamber, Volumatic, and Inspirease), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-commerce), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Aerochamber
Optichamber
Volumatic
Inspirease
By Distribution Channel
Retail Pharmacy
Hospital Pharmacy
E-Commerce
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Aerochamber Segment is Expected to Witness Significant High Growth Over the Forecast Period

The Aerochamber is a spacer used with a metered-dose inhaler that helps control delivery of asthma medication. Aerochambers are witnessed high in demand due to the increased prevalence of asthma, particularly among the elderly. According to the World Health Organization (WHO), the number of persons aged 60 and more will reach two billion by 2050, accounting for 22% of the global population. Aerochambers are gaining popularity due to their improved ability to deliver medicine in a slow and regulated manner. Hence, owing to the above factors, the adoption of these products is likely to increase among the target population, ultimately driving the market growth.

Furthermore, continuous product launches by major players in the market are positively affecting the growth of the segment. For instance, in April 2020 Adherium Limited, a leader in digital inhaled device adherence, remote monitoring, and data management solutions, has signed a heads of terms sales agreement with Monaghan Medical Corporation, the United States subsidiary of Trudell Medical Limited. Monaghan has an established and comprehensive sales team working across the United States supporting AeroChamber, Aerobika and AeroEclipse device commercialization.

Global Asthma Spacer Market

North America is Expected to Dominate the Asthma Spacers Market

North America is expected to dominate the market owing to factors such as the easy availability of technologically advanced products, and rising incidence of asthma coupled with increasing healthcare spending in the region. A rising incidence of asthma especially among elderly population in the United States is among the key factors which contribute to the growth of the studied market in North America.

Key product approvals, high concentration of market players, or manufacturer's presence in the United States are some of the factors driving the growth of the asthma spacers market in the country. For instance, in April 2020 Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation with a spacer, or holding chamber, is an attachment that should always be used with inhaler, from the United States Food and Drug Administration (US FDA). These continuous product approvals in the region are anticipated to drive the growth of the market in the country.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.

Global Asthma Spacer Market

Competitive Landscape

The asthma spacers market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. include Cipla Inc., PARI GmbH, Koninklijke Philips N.V., GSK plc., HAAG-STREIT GROUP, Laboratoire ProtecSom, Monaghan Medical Corporation, Koo Medical Equipment, AGPMED Rossmax International Ltd., and Teleflex among others.

Recent Development

  • In January 2022, Monaghan Medical Corporation (MMC), a leader in the development, manufacture, and marketing of respiratory devices including the AeroChamber Plus, Flow-Vu VHC, AeroEclipse II Nebulizer, and Aerobika Oscillatory Pep Device, is the recipient of the 2021 Zenith Award presented by the American Association for Respiratory Care (AARC). It is the seventh consecutive year MMC has received this prestigious honor.
  • In May 2021 Monaghan Medical Corporation (Monaghan) and Captis announced that their agreement to a three-year contract creating a partnership between two industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold standard medical devices in in two categories medication delivery and Oscillatory Positive Expiratory Pressure/Positive Airway Pressure devices with Captis’ desire to drive process efficiencies and value driven healthcare spending.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing prevalence of chronic respiratory conditions.

      2. 4.2.2 Growing awareness about the benefits of Spacers.

      3. 4.2.3 Rising investments by public and private organizations in research and development activities for product innovation.

    3. 4.3 Market Restraints

      1. 4.3.1 Rising costs of these devices and a lack of awareness among people about the product.

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Aerochamber

      2. 5.1.2 Optichamber

      3. 5.1.3 Volumatic

      4. 5.1.4 Inspirease

    2. 5.2 By Distribution Channel

      1. 5.2.1 Retail Pharmacy

      2. 5.2.2 Hospital Pharmacy

      3. 5.2.3 E-Commerce

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Cipla Inc.

      2. 6.1.2 PARI GmbH

      3. 6.1.3 Koninklijke Philips N.V.

      4. 6.1.4 GSK plc.

      5. 6.1.5 HAAG-STREIT GROUP

      6. 6.1.6 Laboratoire ProtecSom

      7. 6.1.7 Monaghan Medical Corporation

      8. 6.1.8 Koo Medical Equipment

      9. 6.1.9 AGPMED

      10. 6.1.10 Rossmax International Ltd.

      11. 6.1.11 Teleflex

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Asthma Spacers Market market is studied from 2019 - 2027.

The Global Asthma Spacers Market is growing at a CAGR of 6.4% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

PARI GmbH, Koninklijke Philips N.V., HAAG-STREIT GROUP, Cipla Inc., Truedell Medical International are the major companies operating in Global Asthma Spacers Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!